Population
616 consecutive, nontreated patients with stable coronary artery disease
Design
Cohort
Follow-up
median of 17 months
Authors
Loading...
May aid risk stratification in stable CAD; leaves open whether PCSK9 targeting improves outcomes.
Baseline plasma PCSK9 levels, along with hs-CRP and coronary severity scores, independently predict major adverse cardiovascular events in patients with stable coronary artery disease.
Li et al. (2015) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: